ZULIANI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 1.785
EU - Europa 1.774
AS - Asia 818
SA - Sud America 106
AF - Africa 27
Totale 4.510
Nazione #
US - Stati Uniti d'America 1.745
CN - Cina 477
FI - Finlandia 382
SE - Svezia 278
IE - Irlanda 261
SG - Singapore 252
IT - Italia 225
UA - Ucraina 195
DE - Germania 180
BR - Brasile 93
NL - Olanda 70
GB - Regno Unito 61
TR - Turchia 44
RU - Federazione Russa 39
CA - Canada 35
CI - Costa d'Avorio 23
IN - India 22
BE - Belgio 20
AT - Austria 18
CZ - Repubblica Ceca 14
FR - Francia 10
IQ - Iraq 6
PT - Portogallo 6
CL - Cile 5
LT - Lituania 5
ES - Italia 4
HK - Hong Kong 3
MA - Marocco 3
MX - Messico 3
AR - Argentina 2
BD - Bangladesh 2
EC - Ecuador 2
EE - Estonia 2
ID - Indonesia 2
IR - Iran 2
NP - Nepal 2
VE - Venezuela 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
CY - Cipro 1
EG - Egitto 1
GY - Guiana 1
JO - Giordania 1
LI - Liechtenstein 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
Totale 4.510
Città #
Chandler 279
Dublin 261
Jacksonville 214
Singapore 155
Santa Clara 141
Ann Arbor 119
Ashburn 117
Beijing 107
Dearborn 101
Boardman 83
Nanjing 82
Parma 65
Princeton 51
Shanghai 51
Helsinki 42
Izmir 41
San Mateo 40
New York 38
Milan 37
Wilmington 35
Munich 33
Toronto 29
Bremen 25
Los Angeles 25
Moscow 25
Shenyang 24
Abidjan 23
Hebei 23
Turku 23
Nanchang 22
Brussels 20
Jinan 20
Kunming 19
Vienna 18
Hefei 16
Des Moines 13
Seattle 13
Guangzhou 12
Jiaxing 12
The Dalles 12
Woodbridge 12
London 11
Council Bluffs 8
Frankfurt am Main 8
Auburn Hills 7
Changsha 7
Norwalk 7
Nuremberg 7
Pune 7
Tianjin 7
Brno 6
Chengdu 6
Dallas 6
Piacenza 6
Reggio Emilia 6
Bengaluru 5
Bologna 5
Columbus 5
Falkenstein 5
Haikou 5
Marseille 5
Modena 5
Reggio Nell'emilia 5
São Paulo 5
Abbiategrasso 4
Belo Horizonte 4
Brescia 4
Brooklyn 4
Chennai 4
Falls Church 4
Roncadelle 4
Taiyuan 4
Amsterdam 3
Augusta 3
Baghdad 3
Borås 3
Buccinasco 3
Castelo Branco 3
Düsseldorf 3
Grafing 3
Gualtieri 3
Hangzhou 3
Houston 3
Leipzig 3
Olomouc 3
Pavia 3
St Andrews 3
Taizhou 3
Xian 3
Zhengzhou 3
Ankara 2
Brasília 2
Caracas 2
Castelcovati 2
Cereda 2
Cesena 2
Chongqing 2
Contagem 2
Espoo 2
Fairfield 2
Totale 2.728
Nome #
2-Aminobenzimidazoles as new potent H3-antagonists 130
Aminobenzimidazoles as new potent H3-antagonists 113
5-Benzylidene-hydantoins as new EGFR inhibitors with antiproliferative activity 112
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 112
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 112
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 110
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 108
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 108
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 107
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 105
Antiproliferative and proapototic effects of a new combi-molecule on non small cell lung cancer cell lines 102
Meccanismo d’azione di UPR 1024: un nuovo farmaco con attività antiproliferativa in cellule di carcinoma polmonare umano 101
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 97
5-benzylidene-hydantoins as new inhibitors of cell proliferation 96
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 95
CNS access of selected H3-antagonists: ex vivo binding study in rats 94
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 94
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 93
5-benzylidene-hydantoin UPR 1024 acts as EGFR inhibitor and induces DNA damage in A549 NSCLC cell line 92
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 91
Drug repurposing approaches to fight Dengue virus infection and related diseases 91
Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines 89
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 88
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 88
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 87
Advances in Design and Development of Sodium Channel Blockers. 84
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 81
Structure-Property Relationships on Histamine H3-Antagonists: Binding of Phenyl-substituted Alkylthioimidazole Derivatives to Rat Plasma Proteins 79
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 79
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 78
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 78
Relationship between structure and ex-vivo binding of imidazole H3 antagonists to rat brain H3 receptors 77
Three-Dimensional Quantitative Structure-Activity Relationship Studies on Selected MT1 and MT2 Melatonin Receptor Ligands: Requirements for Subtype Selectivity and Intrinsic Activity Modulation 77
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 77
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 77
NMR Analysis of a Series of Imidazobenzoxazines 74
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 73
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 73
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 72
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 70
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 68
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 65
Sodium channel blockers: a patent review (2010 - 2014) 64
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 63
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 62
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 62
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 60
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 59
Sodium channel blockers for neuropathic pain. 57
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 54
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 53
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 51
Fluorescent Ligands for the Histamine H2 Receptor: Synthesis and Preliminary Characterization 50
pH-partition profiles of 4-(3-oxo-1,2-benzisothiazolin-2-yl)phenyl and phenoxyalkanoic acids 37
null 36
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 35
Erratum: Fluorescent ligands for the histamine H 2 receptor: Synthesis and preliminary characterization (Bioorganic & Medicinal Chemistry (2004) 12 (6495-6503)) 34
Totale 4.574
Categoria #
all - tutte 18.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 0 0 0 0 0 0 0 22 55
2020/2021374 6 52 35 12 43 6 54 11 73 16 61 5
2021/2022251 2 5 6 20 11 8 33 35 15 18 27 71
2022/20231.103 119 120 83 76 101 143 19 46 322 16 40 18
2023/2024400 14 41 13 11 39 96 40 23 17 23 31 52
2024/20251.090 56 83 101 115 67 143 52 84 108 131 150 0
Totale 4.574